CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
about
Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells.MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal.Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.Expression and Function of CD44 in Epithelial Ovarian CarcinomaExpression of miR-199a-3p in human adipocytes is regulated by free fatty acids and adipokines.Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma.Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.miR-199a-3p is involved in estrogen-mediated autophagy through the IGF-1/mTOR pathway in osteocyte-like MLO-Y4 cells.Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma.Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1.Serum microRNA-199a/b-3p as a predictive biomarker for treatment response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Noncoding RNA in drug resistant sarcoma.CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.miR‑328‑3p enhances the radiosensitivity of osteosarcoma and regulates apoptosis and cell viability via H2AX.Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.The biology and role of CD44 in cancer progression: therapeutic implications.MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma.
P2860
Q33728298-07D7377A-F6BA-45BF-AEF2-46DA79187349Q33733244-3932BCAD-39B6-46DE-A9DA-AF56DD577567Q33850064-0E253F0A-BA1B-4E5F-B561-91246AC869E5Q36409587-30E4177B-75CB-45E7-BF72-A1B79FCA32FFQ37082994-DEB9E411-599D-4147-A2F8-497AF028AE21Q37218051-809BE513-0AA6-4F36-AF3F-9AA13F81F17DQ37437481-32D71215-1D78-4C95-A0AF-FEE334DD4F91Q37604413-70D9F9E2-0AE8-45D3-92C5-86DE980EA6F2Q37682137-5BD0D2F9-EBA3-4A2F-ACFF-740C2B1D5B92Q38679186-E33E084D-6B43-4809-BEE7-71398341928DQ38726489-D467D2E4-E704-4AA5-A097-2A754210EDADQ38861264-3B4882AB-6A20-452F-A3E6-C69BCAB6DC7AQ40120259-F76B54B3-52B6-4AAE-B92D-753BAC35AF41Q40227278-5C54116B-E075-4A9E-9888-AD73F87FE0ECQ41377011-D0BD1907-C014-4FD6-8AF8-5A0380E759F7Q41924654-509D49FA-3853-4552-8D81-21923A7CD1CDQ48511799-1E952C2E-C2CE-4047-89D2-8E8AD8A6C7A5Q49762971-27BB9457-BF95-46E7-9779-086960978DFCQ49967917-F79C0F95-47C5-43FF-B66A-65A03F2EE3DCQ51117850-361FA5F2-3452-49CD-9AED-AC38EE31808DQ54110894-9FBFDC4B-533A-4C2F-B90F-896AC00F9C40Q55270985-8C03C75E-20DD-43C4-ADF8-815C80DF7DB2
P2860
CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@ast
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@en
type
label
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@ast
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@en
prefLabel
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@ast
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@en
P2093
P2860
P356
P1433
P1476
CD44 is a direct target of miR ...... ve progression in osteosarcoma
@en
P2093
David C Harmon
Edwin Choy
Francis J Hornicek
Henry J Mankin
Jacson K Shen
Zhenfeng Duan
P2860
P2888
P356
10.1038/SREP11365
P407
P50
P577
2015-06-16T00:00:00Z